Ubix Therapeutics
$18.1M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Ubix Therapeutics is currently valued at N/A as of December 22, 2024. The company has raised a total of $48.0M in funding.
Investment Perspective
Ubix Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Ubix Therapeutics Worth in 2025?
As of 2025, Ubix Therapeutics is valued at N/A, based on the company's Later Stage VC funding round in December 22, 2024. This valuation positions Ubix Therapeutics as one of the leading private companies in the sector.
Ubix Therapeutics Valuation History
Ubix Therapeutics's funding history demonstrates steady growth and investor confidence.
How Ubix Therapeutics Valuation is Determined
Private company valuations like Ubix Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Ubix Therapeutics Valuation FAQs
Is Ubix Therapeutics profitable?
Ubix Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Ubix Therapeutics's valuation compare to competitors?
Ubix Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Ubix Therapeutics IPO?
Ubix Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Ubix Therapeutics shares through secondary market platforms.